Literature DB >> 28451538

Plasma Membrane Redox System in the Erythrocytes of Rowers: Pilot Study.

Danila Di Majo1, Valentina Contrò1, Antonino Bianco1, Marco Giammanco1, Maurizio La Guardia1, Marcello Traina1, Patrizia Proia1.   

Abstract

Entities:  

Year:  2017        PMID: 28451538      PMCID: PMC5401922     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

The oxidative stress results from a change in the physiological balance between oxidant and anti-oxidant species. This type of stress is a chemical change in the redox state of cells. The increased production of reactive species is related to an excessive metabolic activation, for example, from an intense physical exercise or an excessive caloric intake (1). In physiological conditions, muscle fibers are provided with an anti-oxidant system able to keep under control the excessive production of Reactive Oxygen Species (ROS). Endogenous and exogenous antioxidants are involved in countering the damage caused by reactive chemical species on muscle skeletal system. High-intensity training is associated with increased oxidative stress, because of the muscular effort required and the activation of all the metabolic pathways for ATP synthesis. Rowing is very demanding of high power maintained over time, mostly produced from aerobic metabolism (2). The aim of this study was to evaluate the reducing activity in plasma and in erythrocytes in a group of rowers compared to a group of sedentary subjects, and then to evaluate the efficiency of the trans-plasma membrane electron transport (TPMET), also known as PMRS, in the erythrocytes of rowers as a compensatory mechanism of cellular redox homeostasis. Twenty-six healthy volunteers who did not practice physical activity at a competitive level (control subjects group) (26.6±2.2 yr) and twenty-two professional rowers were recruited (18.6±3.1 yr). Venous blood samples were collected from rowers and control group after overnight fast. After centrifugation at 3000 rpm for 10 min at 4 °C, plasma was separated from red blood cells. The resultant plasma was transferred to micro centrifuge tubes and used at least in part for ferric-reducing activity power (FRAP) assay. Red blood cells, after removal of buffy coat and upper 15% of the packed red blood cells, were washed two times with cold PBS (3). The ferric reducing activity in plasma and erythrocytes (FRAP) assay was performed (4). The PMRS activity was evaluated by reduction of 1 mM-ferricyanide (FIC) solution in PBS (pH 7.4) in ferrocyanide (FOC), using 1, 10-phenanthroline as an indicator and measuring absorption at 510 nm. All analyses were performed using GraphPad Prism 5 (GraphPad Software Inc., Chicago, IL, USA). The statistical significance level was set at P<0.05. The main finding of this study concern the activity of plasma membrane redox system (PMRS): it has been elevated of 35% in RBCs from rowers than in RBCs from untrained group. The PMRS operated to maintain the ascorbate level in plasma, concerning the compensatory/protective mechanism. The plasma membrane redox system activity varies from 443 to 475μmoL ferrocyanide/mL PRBC/30 min vs the range of 281 to 311 μmoL ferrocyanide/mL PRBC/30 min of the control group. The antioxidant status (FRAP) measured in plasma and in erythrocytes as well as plasma membrane redox system (PMRS) activity for untrained and rower groups are shown in Table 1. Plasma antioxidant capacity levels, measured by FRAP, was 21% lower in rowers group compared to untrained one (P=0.02).
Table 1:

Plasma and erythrocyte antioxidant status and membrane redox of system values of the study partecipants

ParameterUntrained subjects (n= 26)Rowers (n=22)P-value
Plasma
FRAP (μmol/L)581 ± 161460 ± 810.02*
Erythrocytes
FRAP (μmol/L)1691 ± 1281818 ± 4010.17
PMRS (μmol ferrocyanide/mL PBRC/30min)2,96 ± 0,154,59 ± 0,16<0.0001*

Data are expressed as means ± SD. FRAP, ferric reducing ability of plasma and of erythrocytes; PMRS, Plasma Membrane Redox System;

Significant difference by unpaired Student’s t-Test

Plasma and erythrocyte antioxidant status and membrane redox of system values of the study partecipants Data are expressed as means ± SD. FRAP, ferric reducing ability of plasma and of erythrocytes; PMRS, Plasma Membrane Redox System; Significant difference by unpaired Student’s t-Test Definitely, athletes who play maximal aerobic/anaerobic sports have a higher NADH/NADPH level compare with sedentary subjects. In athletes engaged in exhaustive exercise like rowing, there was a significant increase in the oxidative phosphorylation, necessary to support a higher demand of ATP (5). We concluded that, despite extreme exercise like rowing cause an increase of oxidant species production, well-trained athletes that following a healthy lifestyle do not show an oxidative stress condition because intensive but constant training determines an adaptation of the antioxidant system that becomes more efficient, minimizing the redox imbalances.
  4 in total

1.  Increased oxidative stress blood markers in well-trained rowers following two thousand-meter rowing ergometer race.

Authors:  Antonios Kyparos; Ioannis S Vrabas; Michalis G Nikolaidis; Christos S Riganas; Dimitrios Kouretas
Journal:  J Strength Cond Res       Date:  2009-08       Impact factor: 3.775

2.  Oxidative stress and nitrite dynamics under maximal load in elite athletes: relation to sport type.

Authors:  Dejan Cubrilo; Dusica Djordjevic; Vladimir Zivkovic; Dragan Djuric; Dusko Blagojevic; Mihajlo Spasic; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2011-05-12       Impact factor: 3.396

3.  Dietary flavonoids as intracellular substrates for an erythrocyte trans-plasma membrane oxidoreductase activity.

Authors:  Mara Fiorani; Augusto Accorsi
Journal:  Br J Nutr       Date:  2005-09       Impact factor: 3.718

4.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

Authors:  I F Benzie; J J Strain
Journal:  Anal Biochem       Date:  1996-07-15       Impact factor: 3.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.